Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Pancreatic Cancer

Por Chen-Yu Hu, Chen-Yu Hu, Xiang-Ming Xu, Bo Hong, Zhi-Gang Wu, Zhi-Gang Wu, Yun Qian, Tian-Hao Weng, Tian-Hao Weng, Yi-Zhi Liu, Yi-Zhi Liu, Tao-Ming Tang, Tao-Ming Tang, Ming-Hai Wang, Ming-Hai Wang, Ming-Hai Wang, Ming-Hai Wang, Hang-Ping Yao, Hang-Ping Yao
Publicado em 2019-12-01

Preclinical Evaluation of Anticancer Efficacy and Pharmacological Properties of FBA-TPQ, a Novel Synthetic Makaluvamine Analog

Por Sadanandan E. Velu, Ming-Hai Wang, Ruiwen Zhang, Wei Wang, Dwayaja H. Nadkarni, Sukesh Voruganti, Srinivasan Murugesan, Xu Zhang, Xiangrong Zhang, Hongxia Xu
Publicado em 2012-05-01